Interesting comment re the adult trial awaiting BLA outcome. Firstly does not match with Mesoblast's timeline indications and change has not been communicated to market. Secondly, the FDA had indicated the adult trial could not progress until issues with potency assay had been resolved (or something similar ... sure someone can correct me). Does this mean that FDA have said to MSB the trial can't proceed until BLA outcome is determined ?
This feels really strange as I thought one of the alternate directions following original CRL was conducting an additional, well controlled trial in adults/children.
Feels like a loose/loose for MSB. Regardless of BLA outcome, just creates more delays in adult approval or god forbid, if we get another CRL on BLA again major delay.
I'm just hoping this direction reflects some "certainty" by MSB on BLA outcome and a broader strategy, rather than being told they can't proceed with the adult trial by FDA.
If FDA has told them adult trial can't proceed prior to BLA approval, it's a bit hypocritical as they are still happy for ongoing treatment of children in EAP.
- Forums
- ASX - By Stock
- MSB
- 2024 Here we go again.
2024 Here we go again., page-448
-
- There are more pages in this discussion • 496 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.02 |
Change
0.015(1.49%) |
Mkt cap ! $1.164B |
Open | High | Low | Value | Volume |
$1.00 | $1.04 | 94.0¢ | $11.76M | 11.90M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 206912 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 37637 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 206912 | 1.015 |
8 | 195410 | 1.010 |
5 | 95607 | 1.005 |
7 | 208096 | 1.000 |
3 | 103747 | 0.995 |
Price($) | Vol. | No. |
---|---|---|
1.025 | 37637 | 1 |
1.030 | 29757 | 2 |
1.035 | 91225 | 3 |
1.040 | 72457 | 5 |
1.045 | 126212 | 4 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online